Concepedia

Publication | Open Access

Assessment of Efficacy and Safety of Zagotenemab

DOIFull Paper Access

25

Citations

21

References

2024

Year

Adam Fleisher, Leanne Munsie, David Pérahia, Scott W. Andersen, Ixavier A. Higgins, Paula M. Hauck, Albert Lo, John R. Sims, Mark A. Mintun
Neurology

Abstract

This study provides Class II evidence that for patients with early symptomatic AD, zagotenemab does not slow clinical disease progression.

References

YearCitations

Page 1